EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders

Yoshihiro Hayashi iD, Hironori Harada iD

Cancer Science · 2023

DOI: 10.1111/cas.15810 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2023. Verfasst von Yoshihiro Hayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid malignancies, including myelodysplastic syndromes and acute myeloid leukemia, are a group of clonal hematopoietic stem cell (HSC) diseases. The incidence increases with global population aging. Genome sequencing uncovered mutational profiles in patients with myeloid malignancies and healthy elderly individuals. However, the molecular and cellular basis of disease development remains unclear. Accumulating evidence shows mitochondrial involvement in the pathogenesis of myeloid malignancies, aging‐related HSC phenotypes, and clonal hematopoiesis. Mitochondria are dynamic organelles that continuously undergo fission and fusion processes to maintain their function, integrity, and activity. Mitochondria could be a hub of various biological processes that underlie cellular and systemic homeostasis. Thus, mitochondrial dysfunction could directly lead to the disruption of cellular homeostasis and the development of various disorders, including cancer. Notably, emerging data have revealed that mitochondria dynamics also primarily affect not only mitochondrial function and activity but also cellular homeostasis, the aging process, and tumorigenesis. Here, by focusing on mitochondrial dynamics, we highlight the current understanding of mitochondrial roles as a pathobiological mediator of myeloid malignancies and aging‐related clonal hematopoiesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Myeloid, AcuteHumansMitochondrial DynamicsHematopoiesis

Stichwörter der Autor:innen

acute myeloid leukemiaagingclonal hematopoiesismitochondrial dynamicsmyelodysplastic syndromes

Autor:innen und Institutionen

  • Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

ORCID-Profile: Yoshihiro Hayashi, Hironori Harada

Zitieren

APA

Hayashi, Y., & Harada, H. (2023). Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders. Cancer Science. https://doi.org/10.1111/cas.15810

Vancouver

Hayashi Y, Harada H. Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders. Cancer Science. 2023. doi:10.1111/cas.15810

BibTeX
@article{Hayashi2023,
  author = {Hayashi, Yoshihiro and Harada, Hironori},
  title = {Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders},
  journal = {Cancer Science},
  year = {2023},
  doi = {10.1111/cas.15810}
}
Kostenlos starten →